Stay updated on Long-Term Safety of Galegenimab in Geographic Atrophy Clinical Trial
Sign up to get notified when there's something new on the Long-Term Safety of Galegenimab in Geographic Atrophy Clinical Trial page.

Latest updates to the Long-Term Safety of Galegenimab in Geographic Atrophy Clinical Trial page
- Check4 days agoChange DetectedA consolidated Locations section lists all site locations by state and the revision shows v3.3.3. Individual state location subsections (e.g., California Locations, Colorado Locations) were removed.SummaryDifference2%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe page footer revision label was updated from v3.3.1 to v3.3.2.SummaryDifference0.0%

- Check33 days agoChange DetectedThe page shows a site revision update from v3.2.0 to v3.3.1, with no changes to the study content or essential navigation. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check41 days agoChange DetectedThe funding-status notice about a lapse in government funding and where to check operating status has been removed from the page.SummaryDifference0.3%

- Check55 days agoChange DetectedThe study page content appears unchanged between screenshots; only layout and formatting differ. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check83 days agoChange DetectedUpdated version to v3.2.0 and added a government-operating-status notice; removed the prior v3.1.0 tag.SummaryDifference4%

Stay in the know with updates to Long-Term Safety of Galegenimab in Geographic Atrophy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Long-Term Safety of Galegenimab in Geographic Atrophy Clinical Trial page.